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1. Introduction 
Atherosclerotic diseases such as ischemic heart disease and cerebral infarction account for 
the major causes of death in many countries. It is well known that hyperlipidemia is closely 
associated with these diseases (Kodama, 1990). Fish oil consumption reduces lipogenesis 
and induces fatty acid oxidation in liver(Rustan, 1990; Halminski, 1991), and ameliorates 
plasma and hepatic lipid levels (Nestel, 1990). These effects of fish are greatly attributed to 
the action of n-3 polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA) or 
docosahexaenoic acid (DHA). Several studies have reported that n-3 PUFA decreases the 
expression of genes coding for lipogenesis enzymes such as fatty acid synthase (FAS), 
acetyl-CoA carboxylase (ACC), and stearoyl-CoA desaturase (SCD) through the lowering of 
sterol regulatory element binding protein-1 (SREBP-1) (Kim, 1999; Shimano, 1999; Nakatani, 
2002). In addition, n-3 PUFA activates the peroxisome proliferator-activated receptor ┙ 
(PPAR┙) (Krey, 1997). PPAR┙ is a ligand-activated transcription factor that regulates the 
expression of genes involved in triglyceride hydrolysis and fatty acid oxidation (Latruffe, 
1997; Nakatani, 2002; Schoonjans, 1996), such as acyl-CoA oxidase (AOX), lipoprotein lipase 
(LPL), medium-chain acyl-CoA dehydrogenase (MCAD), acyl-CoA synthetase (ACS), and 
uncoupling protein-2 (UCP-2).  
Cholesterol is crucial for the components of animal cell membranes, and for the synthesis of 
bile acid and steroid hormone. Cholesterol in the inner cavity of the small intestine are 
entered in to epithelial cells by Niemann-Pick C1 like-1 (NPC1L1) protein on the brush 
border of epithelial cells of the small intestine (Davis, 2004), and cholesterol is released into 
the lymph duct. It is well known that cholesterols, including 22- and 24-hydroxy cholesterol, 
act as ligands for liver X receptor (LXR)  (Schultz, 2000). LXR, a nuclear receptor, forms a 
heterodimer together with the retinoid X receptor (RXR) and combines with LXR element 
(LXRE) at the promoter of target genes to control transcription. LXR target genes include 
cholesterol 7-hydroxylase (CYP7A1), ATP-binding cassette transporter (ABC)A1, ABCG1, 
and SREBPs, which are highly involved in cholesterol metabolism (Repa, 2000; Peet, 1998). 
We previously indicated that 20en% fish oil diet dramatically inhibited hepatic lipids 
accumulation in female C57BL/6J mice fed 2% cholesterol (Hirako, 2010). In this study, we 
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determined whether 2 or 5en% fish oil, eqivalent to 10 or 25% of the total fat energy, 
improves lipid metabolism in high cholesterol diet fed male C57BL/6J mice. Mice were 
given SO diet consisted of 20en% safflower oil, 2FO diet consisted of 2en% fish oil plus 
18en% safflower oil, 5FO diet consisted of 5en% fish oil plus 15en% safflower oil, and 
SO/CH, 2FO/CH, 5FO/CH are consisted of SO, 2FO, 5FO with 2%cholesterol. The body fat 
composition of mice was examined radiographically using an X-ray CT for experimental 
animals. Blood parameter and hepatic lipids were measured using enzymatic methods. 
Hepatic mRNA expression levels were measured by real-time RT-PCR. 
2. Results and discussion  
2.1 Body weight and tissue weight did not change with the low dose fish oil feeding in 
male C57BL/6J mice  
Final body weights were not significantly different among the groups. No large difference in 
weights of the white adipose tissue around the uterus and brown adipose tissue from the 
interscapular region between the groups was observed. In previous study, we reported that 
body weight gain was significantly decreased in female C57BL/6J mice fed 20 en% fish oil 
(Hirako, 2010). However, our study observed that 5 en% fish oil feeding in female C57BL/6J 
mice did not modify body weights (data not shown). These results revealed that 2 and 5 en% 
fish oil feeding in male C57BL/6J mice did not modify body weight and adipose tissue weight  
 
 
Representative X-ray CT images of mice fed SO, SO/CH, 2FO, 2FO/CH, 5FO, and 5FO/CH for 8 
weeks, at the L3 level (upper). The areas indicated with pink, yellow, and light-blue are visceral fat, 
subcutaneous fat, and muscle, respectively. CT-estimated amounts of visceral fat and subcutaneous fat 
in the abdominal area of L2–L4(bottom). Values represent means ± S.D. (n=5). Means with different 
letters are different at the p<0.05 level by Fisher’s protected least significant difference (PLSD) test. 
Fig. 1. CT-based fat tissues composition analysis of 16-week-old male C57BL/6J mice.  
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as well as female C57BL/6J mice. CT scan analysis showed that visceral and subcutaneous 
fat mass were significantly increased in the 5FO and 5FO/CH groups, but not changed by 
cholesterol feeding (Figure 1). Meanwhile, these levels were high in all group compared 
with the fat mass in the female C57BL/6J mice (0.45±0.28cm3 visceral fat in male C57BL/6J 
mice fed the SO diet and 0.24±0.13 cm3  visceral fat in female C57BL/6J mice fed the SO diet).  
2.2 Hepatic tissue histology and lipid levels modified with the low dose fish oil 
feeding in male C57BL/6J mice 
Although the liver weight significantly increased in the SO/CH group compared with the 
SO group, there was no difference in the fish oil groups compared with the SO group (SO: 
0.96 ± 0.10, SO/CH: 1.31 ± 1.2, 2FO: 1.00 ± 0.13, 2FO/CH: 1.11 ± 0.12, 5FO: 0.92 ± 0.08, 
5FO/CH: 1.12 ± 0.12, p<0.05). The liver size in the SO/CH group had enlarged, and the 
entire surface had a pale color, suggestive of increased lipid storage. In contrast, the livers of 
the 2FO/CH and 5FO/CH groups were less pale and had a normal reddish appearance 
(data not shown). The hepatic tissues showed numerous lipid droplets in the livers of 
SO/CH group. However, these lipid droplets were markedly decreased in the 2FO/CH and 
5FO/CH groups (Figure 2A). These results in the microscopic images of hepatic tissue were 
confirmed in hepatic lipid content reductions. Hepatic TG levels in both 2FO/CH and 
5FO/CH group significantly decreased to about 50% of that in the SO/CH group. Hepatic 
TC levels also decreased by about 40% in both 2FO/CH and 5FO/CH group compared with 
the SO/CH group(Figure 2B). Fabbrini suggested that hepatic lipid accumulation is 
considered a risk factor for fatty liver and steatohepatitis, which promote the development  
 
 
H&E-stained liver sections (A), total cholesterol (TC) and triglycerides (TG) (B) in mice fed SO, SO/CH, 
2FO, 2FO/CH, 5FO, and 5FO/CH for 8. Values represent means ± S.D. (n=5). Means with different 
letters are different at the p<0.05 level by Fisher’s protected least significant difference (PLSD) test. 
Fig. 2. Liver tissue histology and lipid levels of 16-week-old male C57BL/6J mice.  
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of insulin resistance, dyslipidemia, and cardiovascular disease (Fabbrini, 2010). In this 
study, lipid deposition caused by high cholesterol feeding significantly decreased in the 
2FO/CH and 5FO/CH groups, in which low dose fish oil was used as the lipid source. We 
confirmed that the 2 en% fish oil exerts ameliorating effects on hepatic lipid accumulation 
due to dietary cholesterol consumption in male C57BL/6J mice. 
2.3 The hepatic mRNA levels of lipid metabolism-regulating genes modfied with the 
fish oil or cholesterol feeding in male C57BL/6J mice 
The hepatic mRNA levels of lipid metabolism-regulating genes are shown in Table 1. The 
mRNA levels of SREBP-1c, which is transcription factor of genes related to lipogenesis, were 
not significantly changed in all groups. Low dose fish oil or cholesterol feeding did not 
particularly affect in FAS mRNA. However, SCD1 mRNA levels significantly decreased in 
the fish oil groups regardless of the addition the addition of cholesterol, compared with the 
SO/CH group. Previous studies showed that fish oil feeding decreases SREBP1c mRNA 
expression and/or mature protein production and results in the inhibition of SREBP1 target 
genes, such as ACC, FAS, and SCD-1 (Kim, 1999; Nakatani, 2002).  In this study, different 
results were observed, suggesting that the inhibitory effect of fish oil on fatty acid 
biosynthesis is more clear at high dose fish oil. 
 
The mRNA expression levels in liver of  male C57BL/6J mice fed SO, SO/CH, 2FO, 2FO/CH, 5FO, and 
5FO/CH for 8 weeks. Values represent means ± S.D. (n=4-5). Means with different letters are different 
at the p<0.05 level by Fisher’s protected least significant difference (PLSD) test.  
Table 1. Expression of genes associated with lipid metabolism in the liver  
The mRNA levels of PPAR┙ and AOX, genes involved in fatty acid oxidation, were 
significantly higher in the fish oil groups regardless of the addition of cholesterol. However, 
the mRNA levels of UCP-2, which is involved in heat production, were unaffected by low 
dose fish oil or cholesterol feeding. The mRNA levels of ABCG5 and ABCG8, genes 
involved in cholesterol transport into the bile, were significantly induced with the 
cholesterol addition . Biliary cholesterol excretion increases due to the upregulation of these 
genes (Repa, 2002). These increases in ABCG5 and ABCG8 mRNA by cholesterol feeding are 
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crucial for the maintenance of cholesterol homeostasis. Indeed, the mRNA levels of CYP7A1, 
the rate-limiting gene in bile acid synthesis, were significantly increased in all cholesterol-
supplemented groups. However, no such increases were observed in the expression of 
CYP8B1 mRNA. The synthesis of bile acid in the liver is important in the catabolic pathway 
of cholesterol. The bile acid systhesis is controlled by CYP7A1 (Berge, 2000). In this study, 
the mRNA levels of CYP7A1 were not significantly affected by fish oil feeding, but its levels 
significantly increased when cholesterol was added. This is consistent with previous 
observation that CYP7A1 mRNA level is increased on the addition of cholesterol to maintain 
the homeostasis of cholesterol. 
3. Conclusion 
Body weight gains and adipose tissue weights did not change with the low dose fish oil 
feeding in male C57BL/6J mice. Hepatic triglyceride and total cholesterol levels of the 
SO/CH group were dramatically increased compared to the SO group. However, in 
2FO/CH and 5FO/CH groups, the hepatic lipids were significantly decreased compared to 
the SO/CH group. Low dose fish oil or cholesterol feeding did not particularly affect in 
SREBP-1C and FAS mRNA levels. But, PPAR┙ and AOX mRNA levels were significantly 
higher in the fish oil groups regardless of the cholesterol addition. The present study 
indicates that low dose fish oil obviously improved the hepatic lipid accumulation by high 
cholesterol diet. And, this improving effect is partly due to the fatty acid degradation, which 
was facilitated by increased expression of fatty acid oxidation-related genes, such as AOX. 
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